GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,272,000 | -4.0% | 58,994 | +7.5% | 0.07% | -8.6% |
| Q3 2016 | $2,367,000 | +8.1% | 54,883 | +8.6% | 0.08% | +2.5% |
| Q2 2016 | $2,190,000 | +8.6% | 50,534 | +1.6% | 0.08% | -7.1% |
| Q1 2016 | $2,016,000 | +17.1% | 49,726 | +16.6% | 0.08% | +9.0% |
| Q4 2015 | $1,721,000 | +39.9% | 42,649 | +33.3% | 0.08% | -18.8% |
| Q3 2015 | $1,230,000 | -10.6% | 31,999 | -3.2% | 0.10% | -2.0% |
| Q2 2015 | $1,376,000 | +2.4% | 33,040 | +13.5% | 0.10% | +4.3% |
| Q1 2015 | $1,344,000 | +40.0% | 29,112 | +29.6% | 0.09% | -9.6% |
| Q4 2014 | $960,000 | +33.3% | 22,463 | +43.4% | 0.10% | +19.5% |
| Q3 2014 | $720,000 | +51.3% | 15,662 | +76.0% | 0.09% | +35.9% |
| Q2 2014 | $476,000 | -27.4% | 8,900 | -27.5% | 0.06% | +33.3% |
| Q1 2014 | $656,000 | +101.2% | 12,284 | +101.3% | 0.05% | -4.0% |
| Q4 2013 | $326,000 | +74.3% | 6,101 | +62.9% | 0.05% | +31.6% |
| Q2 2013 | $187,000 | – | 3,745 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |